CIK 0001534969 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SERA PROGNOSTICS, INC.
Sign in to watch- Ticker
- SERA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 261911522
- Phone
- (801) 990-0520
- Business address
- 2749 E. PARLEYS WAY, SUITE 200, SALT LAKE CITY, UT, 84109
- Former names
- SERA PROGNOSTICS, INC.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $79,563
- in 6 filings
Net −$79,563. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-11 | Jackson Benjamin General Counsel | Sale | −2,179 | $2.01 | $4K | 161,756 |
| 2026-06-09 | Aerts Austin Chief Financial Officer | Sale | −5,440 | $2.08 | $11K | 303,227 |
| 2026-06-09 | Lindgardt Zhenya Chief Executive Officer | Sale | −20,755 | $2.08 | $43K | 871,999 |
| 2026-06-08 | Lawrence Sandra AJ Director | Sale 10b5-1 | −1,560 | $2.15 | $3K | 16,473 |
| 2026-05-29 | Anderson Dyaarl Lee Jr. Chief Commercial Officer | Grant or award | +3,168 | $1.84 | $6K | 82,737 |
| 2026-05-29 | Jackson Benjamin General Counsel | Grant or award | +5,000 | $1.84 | $9K | 163,935 |
| 2026-03-12 | Lindgardt Zhenya Chief Executive Officer | Grant or award | +154,440 | 892,754 | ||
| 2026-03-12 | Lindgardt Zhenya Chief Executive Officer | Grant or award · Stock Option (right to buy) | +239,442 | 239,442 | ||
| 2026-03-12 | Jackson Benjamin General Counsel | Grant or award | +44,215 | 158,935 | ||
| 2026-03-12 | Jackson Benjamin General Counsel | Grant or award · Stock Option (right to buy) | +68,550 | 68,550 | ||
| 2026-03-12 | Inglis Tiffany Eul Davis Chief Medical Officer | Grant or award | +17,437 | 92,437 | ||
| 2026-03-12 | Inglis Tiffany Eul Davis Chief Medical Officer | Grant or award · Stock Option (right to buy) | +27,034 | 27,034 | ||
| 2026-03-12 | Anderson Dyaarl Lee Jr. Chief Commercial Officer | Grant or award | +12,455 | 79,569 | ||
| 2026-03-12 | Anderson Dyaarl Lee Jr. Chief Commercial Officer | Grant or award · Stock Option (right to buy) | +19,310 | 19,310 | ||
| 2026-03-12 | Aerts Austin Chief Financial Officer | Grant or award | +44,215 | 308,667 | ||
| 2026-03-12 | Aerts Austin Chief Financial Officer | Grant or award · Stock Option (right to buy) | +68,550 | 68,550 | ||
| 2026-03-11 | Lindgardt Zhenya Chief Executive Officer | Sale | −2,973 | $2.04 | $6K | 738,314 |
| 2026-03-11 | Kearney Paul Chief Data Officer | Sale | −1,396 | $2.04 | $3K | 163,961 |
| 2026-03-11 | Jackson Benjamin General Counsel | Sale | −1,027 | $2.04 | $2K | 114,720 |
| 2026-03-11 | Harrison Robert Gardner Chief Information Officer | Sale | −716 | $2.04 | $1K | 76,712 |
Page 3 of 7 · 130 trades